You are here: Industry Insights > COVID-19

News List

GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment WorldPharmaNews
November 22, 2021
GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced US government contracts totalling approximately $1 billion[1] (USD) to purchase sotrovimab...
New Analyses of Two AZD7442 Covid-19 Trials Confirm Robust Efficacy and Long-Term Prevention in High-Risk Populations AmericanPharmaceuticalReview
November 22, 2021
New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials both showed robust efficacy from a one-time intramuscular (IM) dose of the long-acting antibody (LAAB) combination.
Government transfers AYUSH-64 COVID drug technology to 46 companies to meet growing demand ExpressPharma
November 22, 2021
The Central Council for Research in Ayurvedic Sciences (CCRAS) has transferred the technology of AYUSH-64, an “effective” drug in mild and asymptomatic and mild-to-moderate cases of COVID-19...
Pfizer to supply ten million courses of Covid-19 oral antiviral to the US Pharmaceutical-Technology
November 22, 2021
The US Government has signed an agreement with Pfizer to procure ten million courses of the company’s Covid-19 oral antiviral candidate, Paxlovid (PF-07321332; ritonavir)...
Chinese mainland reports 8 locally transmitted COVID-19 cases NMPA
November 22, 2021
The Chinese mainland on Nov 18 reported eight new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 19.
EC approves Celltrion’s COVID-19 mAb Regkirona PharmaTimes.
November 19, 2021
The European Commission (EC) has authorised Celltrion’s COVID-19 monoclonal antibody (mAb) treatment Regkirona (regdanvimab, CT-P59), the company announced yesterday.
Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose PharmaTimes.
November 19, 2021
Following a review of evidence by the Joint Committee on Vaccination and Immunisation (JCVI), the UK Health Security Agency (UKHSA) has published new clinical guidance on vaccinations for 12 to 17 year olds.
GSK and Vir to supply Covid-19 antibody treatment doses to US Pharmaceutical-Business-Review
November 19, 2021
GlaxoSmithKline (GSK) and Vir Biotechnology have secured contracts from the US government for nearly $1bn to supply their Covid-19 antibody treatment, sotrovimab.
Less Than One Year After Approval, Two Billion Doses of AstraZeneca’s COVID-19 Vaccine Have Been Supplied Globally AmericanPharmaceuticalReview
November 19, 2021
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the last 11 months.
Pfizer to provide U.S. government with 10 million treatment courses of investigational oral antiviral candidate to help combat COVID-19 WorldPharmaNews
November 19, 2021
Pfizer Inc. (NYSE: PFE) today announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID™ (PF-07321332; ritonavir)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page